☰

Charles E. Mays, Ph.D. - Publications

Affiliations: 
2010 University of Kentucky, Lexington, KY 
Area:
Virology Biology, Neurobiology Biology, Microbiology Biology
Tree Info Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Mays CE, Trinh THT, Telling G, Kang HE, Ryou C. Endoproteolysis of cellular prion protein by plasmin hinders propagation of prions. Frontiers in Molecular Neuroscience. 15: 990136. PMID 36117913 DOI: 10.3389/fnmol.2022.990136  0.724
2019 Mays CE, Armijo E, Morales R, Kramm C, Flores A, Tiwari A, Bian J, Telling GC, Pandita TK, Hunt CR, Soto C. Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70). The Journal of Biological Chemistry. PMID 31320473 DOI: 10.1074/Jbc.Ra118.006186  0.372
2019 Kang SG, Mays CE, Daude N, Yang J, Kar S, Westaway D. Proteasomal Inhibition Redirects the PrP-Like Shadoo Protein to the Nucleus. Molecular Neurobiology. PMID 31129810 DOI: 10.1007/S12035-019-1623-1  0.473
2019 Lyon A, Mays CE, Borriello F, Telling GC, Soto C, Pritzkow S. Application of PMCA to screen for prion infection in a human cell line used to produce biological therapeutics. Scientific Reports. 9: 4847. PMID 30890734 DOI: 10.1038/S41598-019-41055-X  0.366
2018 Dhouafli Z, Cuanalo-Contreras K, Hayouni EA, Mays CE, Soto C, Moreno-Gonzalez I. Inhibition of protein misfolding and aggregation by natural phenolic compounds. Cellular and Molecular Life Sciences : Cmls. PMID 30030591 DOI: 10.1007/S00018-018-2872-2  0.301
2018 Mercer RCC, Daude N, Dorosh L, Fu ZL, Mays CE, Gapeshina H, Wohlgemuth SL, Acevedo-Morantes CY, Yang J, Cashman NR, Coulthart MB, Pearson DM, Joseph JT, Wille H, Safar JG, et al. A novel Gerstmann-Sträussler-Scheinker disease mutation defines a precursor for amyloidogenic 8 kDa PrP fragments and reveals N-terminal structural changes shared by other GSS alleles. Plos Pathogens. 14: e1006826. PMID 29338055 DOI: 10.1371/Journal.Ppat.1006826  0.364
2016 Mays CE, Soto C. The stress of prion disease. Brain Research. PMID 27060771 DOI: 10.1016/J.Brainres.2016.04.009  0.3
2016 Stocki P, Sawicki M, Mays CE, Hong SJ, Chapman DC, Westaway D, Williams DB. Inhibition of the FKBP family of peptidyl prolyl isomerases induces abortive translocation and degradation of the cellular prion protein. Molecular Biology of the Cell. PMID 26764098 DOI: 10.1091/Mbc.E15-10-0729  0.468
2015 Mays CE, van der Merwe J, Kim C, Haldiman T, McKenzie D, Safar JG, Westaway D. Prion infectivity plateaus and conversion to symptomatic disease originate from falling precursor levels and increased oligomeric PrPSc species. Journal of Virology. PMID 26423957 DOI: 10.1128/JVI.02142-15  0.404
2015 Lau A, McDonald A, Daude N, Mays CE, Walter ED, Aglietti R, Mercer RC, Wohlgemuth S, van der Merwe J, Yang J, Gapeshina H, Kim C, Grams J, Shi B, Wille H, et al. Octarepeat region flexibility impacts prion function, endoproteolysis and disease manifestation. Embo Molecular Medicine. 7: 339-56. PMID 25661904 DOI: 10.15252/Emmm.201404588  0.376
2014 Mays CE, Kim C, Haldiman T, van der Merwe J, Lau A, Yang J, Grams J, Di Bari MA, Nonno R, Telling GC, Kong Q, Langeveld J, McKenzie D, Westaway D, Safar JG. Prion disease tempo determined by host-dependent substrate reduction. The Journal of Clinical Investigation. 124: 847-58. PMID 24430187 DOI: 10.1172/Jci72241  0.428
2014 Mays CE, Coomaraswamy J, Watts JC, Yang J, Ko KW, Strome B, Mercer RC, Wohlgemuth SL, Schmitt-Ulms G, Westaway D. Endoproteolytic processing of the mammalian prion glycoprotein family. The Febs Journal. 281: 862-76. PMID 24286250 DOI: 10.1111/Febs.12654  0.324
2013 Herbst A, Banser P, Velasquez CD, Mays CE, Sim VL, Westaway D, Aiken JM, McKenzie D. Infectious prions accumulate to high levels in non proliferative C2C12 myotubes. Plos Pathogens. 9: e1003755. PMID 24244171 DOI: 10.1371/Journal.Ppat.1003755  0.447
2012 Mays CE, Joy S, Li L, Yu L, Genovesi S, West FG, Westaway D. Prion inhibition with multivalent PrPSc binding compounds. Biomaterials. 33: 6808-22. PMID 22748770 DOI: 10.1016/J.Biomaterials.2012.06.004  0.312
2011 Westaway D, Genovesi S, Daude N, Brown R, Lau A, Lee I, Mays CE, Coomaraswamy J, Canine B, Pitstick R, Herbst A, Yang J, Ko KW, Schmitt-Ulms G, Dearmond SJ, et al. Down-regulation of Shadoo in prion infections traces a pre-clinical event inversely related to PrP(Sc) accumulation. Plos Pathogens. 7: e1002391. PMID 22114562 DOI: 10.1371/Journal.Ppat.1002391  0.472
2011 Mays CE, Yeom J, Kang HE, Bian J, Khaychuk V, Kim Y, Bartz JC, Telling GC, Ryou C. In vitro amplification of misfolded prion protein using lysate of cultured cells. Plos One. 6: e18047. PMID 21464935 DOI: 10.1371/Journal.Pone.0018047  0.741
2011 Ryou C, Titlow WB, Mays CE, Bae Y, Kim S. The suppression of prion propagation using poly-L-lysine by targeting plasminogen that stimulates prion protein conversion. Biomaterials. 32: 3141-9. PMID 21288569 DOI: 10.1016/J.Biomaterials.2011.01.017  0.72
2011 Mays CE, Ryou C. Plasminogen: A cellular protein cofactor for PrPSc propagation. Prion. 5: 22-7. PMID 21191173 DOI: 10.4161/Pri.5.1.14460  0.739
2011 Ryou C, Mays CE. Prions Molecular Aspects of Infectious Diseases. 129-149.  0.401
2010 Mays CE, Ryou C. Plasminogen stimulates propagation of protease-resistant prion protein in vitro. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 5102-12. PMID 20732953 DOI: 10.1096/Fj.10-163600  0.728
2010 Lim YB, Mays CE, Kim Y, Titlow WB, Ryou C. The inhibition of prions through blocking prion conversion by permanently charged branched polyamines of low cytotoxicity. Biomaterials. 31: 2025-33. PMID 20022103 DOI: 10.1016/J.Biomaterials.2009.11.085  0.68
2009 Kim Y, Han B, Titlow W, Mays CE, Kwon M, Ryou C. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations. Antiviral Research. 84: 185-93. PMID 19748523 DOI: 10.1016/J.Antiviral.2009.09.002  0.752
2009 Mays CE, Titlow W, Seward T, Telling GC, Ryou C. Enhancement of protein misfolding cyclic amplification by using concentrated cellular prion protein source. Biochemical and Biophysical Research Communications. 388: 306-10. PMID 19664595 DOI: 10.1016/J.Bbrc.2009.07.163  0.713
2009 Kim Y, Song J, Mays CE, Titlow W, Yoon D, Ryou C. Changes in gene expression of kringle domain-containing proteins in murine brains and neuroblastoma cells infected by prions. Molecular and Cellular Biochemistry. 328: 177-82. PMID 19322640 DOI: 10.1007/S11010-009-0087-4  0.672
2008 Ryou C, Mays CE. Prion propagation in vitro: are we there yet? International Journal of Medical Sciences. 5: 347-53. PMID 19015743 DOI: 10.7150/Ijms.5.347  0.743
2008 Mays CE, Kang HE, Kim Y, Shim SH, Bang JE, Woo HJ, Cho YH, Kim JB, Ryou C. CRBL cells: establishment, characterization and susceptibility to prion infection. Brain Research. 1208: 170-80. PMID 18395703 DOI: 10.1016/J.Brainres.2008.02.103  0.703
2007 Ryou C, Kim J, Mays C, Kang HE, Shim SH, Bang JE, Cho Y, Woo H, Lafferre L, Kim Y. Establishment and Characterization of an Immortalized Mouse Cerebellar Cell Line The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A463-B  0.634
Show low-probability matches.